George Syrmalis
InvestorCEO, Bioscience Equity Partners S.A. at Bioscience Equity Partners
Sydney Australia, Europe, and the USA
Find your path to George
18 people in our graph share verified history with George — schools, employers, funds. One of them is your warm intro.
Ben PerryunlockedGeorge: together at UCB (2007–2008)
×11George: together at UCB
About
George Syrmalis is CEO of Bioscience Equity Partners S.A. (BEP). In an interview with Medical Plastics News, he discussed how early-stage medical device companies in Europe and North America need to move beyond scientific strength toward institutional readiness to attract cross-border and sovereign capital, including from the Gulf and Asia.
Invests in
BiotechDigital HealthMedical Devices
Experience
- Bioscience Equity PartnersFounder and Chief Executive Officercurrent2022 — presentSydney, New South Wales, Australia
- MedSyntraBoard Membercurrent2021 — presentUnited States
- Saudi Confidential CompanyMember of the Board of Advisorscurrent2022 — presentRiyadh, Saudi Arabia
- The iQ Group GlobalFounder2010 — 2022Greater Sydney Area
- OncoTEX Inc.Executive Chairman2021 — 2022Austin, Texas, United States
- Intelligent Bio SolutionsFounder and CEO2017 — 2019United States
- UCBExecutive Director Medical Affairs & QPPV2007 — 2009Brussels Metropolitan Area
- AntisomaGroup Chief Executive Officer1995 — 2005Europe
- The Bionuclear GroupFounder and CEO1995 — 2005Europe
- Security Forces Hospital - RiyadhNuclear Medicine Medical Registrar1989 — 1994Riyadh, Saudi Arabia
Skills & more
Healthcare Investment BankingStrategy57Strategic Planning16Management17Leadership9Board OperationBoard LevelBoard AdministrationBoard GovernancePrivate EquityFund ManagementCommercialization47
+12 more
BiotechnologyLife SciencesClinical DevelopmentMedical DevicesLifesciencesSales EffectivenessDrug DiscoveryBusiness DevelopmentScienceVenture CapitalClinical TrialsTechnology TransferLanguages English · French
- Fellow Royal Society of Medicine — Royal Society of Medicine
- Academy of Phycisians in Clinical Research — Academy of Physicians in Clinical Research
- New York Academy of Sciences — The New York Academy of Sciences
- Australian and New Zealand Society for Nuclear Medicine — Australian and New Zealand Society of Nuclear Medicine
- American College of Nuclear Physicians — American College of Nuclear Medicine
From George's professional profile.
Frequently asked questions
- Who is George Syrmalis?
- George Syrmalis is CEO of Bioscience Equity Partners S.A. (BEP). In an interview with Medical Plastics News, he discussed how early-stage medical device companies in Europe and North America need to move beyond scientific strength toward institutional readiness to attract cross-border and sovereign capital, including from the Gulf and Asia.
- Where does George Syrmalis work?
- George Syrmalis is CEO, Bioscience Equity Partners S.A. at Bioscience Equity Partners.
- What does George Syrmalis invest in?
- George Syrmalis invests in Biotech, Digital Health, Medical Devices.
- Where did George Syrmalis go to school?
- George Syrmalis studied at University of California (M.D. Ph.D., Radiation Immunology/Nuclear Medicine).
Same school
Also attended University of California6
Shared employers
Also worked at UCB25
Ben PerryInvestor at MedicxiStephen RapeckiInvestor at MedicxiMary PattonScientific Advisory Board at InnoCom Bio EquitiesMiguel ForteAdvisor at Delin VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONSam GrayManaging Partner at Apposite Capital
+ 19 more
